Stephen Hodi
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Galectins and Cancer Biology
- Immune cells in cancer
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 5
- Peptidase Inhibition and Analysis 2
- CAR-T cell therapy research 2
- Inflammatory Biomarkers in Disease Prognosis 1
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Nicolas Mach (3 shared papers)Armando Santoro (3 shared papers)Tyler A. Longmire (3 shared papers)Toshihiko Doi (3 shared papers)Giuseppe Curigliano (3 shared papers)Sofie Wilgenhof (3 shared papers)David Tai (1 shared paper)Sabine Gutzwiller (1 shared paper)
- Journals
- Blood (3 papers)Neuro-Oncology (1 paper)Cancer Research (1 paper)Annals of Oncology (1 paper)Clinical Trials (1 paper)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Stephen Hodi
8 papers receiving 77 citations
Peers
Comparison fields: 5 of 19
- Oncology 61
- Immunology 38
- Internal Medicine 4
- Pathology and Forensic Medicine 16
- Genetics 5
Countries citing papers authored by Stephen Hodi
This map shows the geographic impact of Stephen Hodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Hodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Hodi more than expected).
Fields of papers citing papers by Stephen Hodi
This network shows the impact of papers produced by Stephen Hodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Hodi. The network helps show where Stephen Hodi may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Hodi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 33 | |
| 2 | 2019 | 22 | |
| 3 | 2023 | 5 | |
| 4 | 2007 | 5 | |
| 5 | 2015 | 4 | |
| 6 | 2014 | 4 | |
| 7 | 2018 | 2 | |
| 8 | 2019 | 2 |
About Stephen Hodi
Stephen Hodi is a scholar working on Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology, having authored 8 papers that have together received 77 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lymphoma Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers), CAR-T cell therapy research (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Immunotherapy and Immune Responses (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Oncology (61 citations), Immunology (38 citations), Internal Medicine (4 citations), Pathology and Forensic Medicine (16 citations) and Genetics (5 citations). Stephen Hodi has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Nicolas Mach, Armando Santoro, Tyler A. Longmire, Toshihiko Doi, Giuseppe Curigliano, Sofie Wilgenhof, David Tai, Sabine Gutzwiller, Hans Gelderblom and Patrick M. Forde. Their work appears in journals such as Blood, Neuro-Oncology, Cancer Research, Annals of Oncology and Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.